Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
The primary (vial) labels of the affected vials of m0630 were mislabeled with an incorrect concentration of 11.2 mcg/ml. additionally some customers might also have received a certificate of analysis (coa) stating the same incorrect concentration. the correct concentration is 23.5 mcg/ml.